Published in Brain on June 01, 1973
Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet (2004) 1.70
KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet (2011) 1.66
Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II. J Clin Invest (2008) 1.61
WNK1/HSN2 mutation in human peripheral neuropathy deregulates KCC2 expression and posterior lateral line development in zebrafish (Danio rerio). PLoS Genet (2013) 0.86
Thermosensory and mechanosensory perception in human genetic disease. Hum Mol Genet (2009) 0.81
A new neurological rat mutant "mutilated foot". J Anat (1981) 0.79
Congenital insensitivity to pain: a 20 year follow up. J Neurol Neurosurg Psychiatry (1994) 0.79
Soradic ulcerative mutilating acropathy with imbalance of free amino acids in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry (1975) 0.75
Thomas John (Jock) Murray, OC, MD, FRCP(C), MACP, LLD(HON), DSc(Hon), FRCP(Lon): a conversation with the editor. Interview by William Clifford Roberts. Proc (Bayl Univ Med Cent) (2003) 0.75
Autosomal recessive peripheral sensory neuropathy in 3 non-Ashkenazi Jewish families. J Med Genet (1980) 0.75
WNK1/HSN2 isoform and the regulation of KCC2 activity. Rare Dis (2013) 0.75
Editorial: Insensitivity to pain. Br Med J (1973) 0.75
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med (2000) 4.50
The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci (1994) 3.53
THE RELATIVE PREVALENCE OF BACTERIA IN AN IMHOFF TANK. Am J Public Health (N Y) (1923) 3.40
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS? Neurology (2007) 3.17
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
A population-based study of multiple sclerosis in twins. N Engl J Med (1986) 2.59
Dr Samuel Johnson's movement disorder. Br Med J (1979) 2.51
On the death of house officers. Ann Intern Med (1998) 2.34
Visual acuity and contrast sensitivity in multiple sclerosis--hidden visual loss: an auxiliary diagnostic test. Brain (1977) 2.01
Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci (1993) 1.87
Patterns of cannabis use among patients with multiple sclerosis. Neurology (2004) 1.78
The restless leg syndrome. Can Med Assoc J (1967) 1.62
Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation. Mult Scler (2009) 1.52
A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry (2005) 1.50
Multiple sclerosis in childhood: clinical profile in 125 patients. J Pediatr (1987) 1.48
A population-based study of multiple sclerosis in twins: update. Ann Neurol (1993) 1.46
Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain (1994) 1.42
Characteristics of patients found not to have multiple sclerosis. Can Med Assoc J (1984) 1.42
Relevance in undergraduate neurological teaching. Can J Neurol Sci (1977) 1.38
Treatment of essential tremor with propranolol. Can Med Assoc J (1972) 1.36
A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci (1992) 1.32
Auditory brainstem responses in postconcussion syndrome. Arch Neurol (1981) 1.26
Concepts in undergraduate neurological teaching. Clin Neurol Neurosurg (1977) 1.24
Complexation-induced unfolding of heterocyclic ureas. Simple foldamers equilibrate with multiply hydrogen-bonded sheetlike structures. J Am Chem Soc (2001) 1.14
Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci (1985) 1.07
Long-term therapy of essential tremor with propranolol. Can Med Assoc J (1976) 1.07
Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis. Brain (1981) 1.04
Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci (2003) 0.99
Presidential Address: XVIII Canadian Congress of Neurological Sciences. The neurologist as educator. Can J Neurol Sci (1983) 0.97
Predicting sun spots using a layered perceptron neural network. IEEE Trans Neural Netw (1996) 0.96
Effect of body temperature on visual evoked potential delay and visual perception in multiple sclerosis. J Neurol Neurosurg Psychiatry (1977) 0.96
Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression. First estimates. Int J Technol Assess Health Care (2000) 0.95
Essential tremor. Can Med Assoc J (1981) 0.93
The scope of neurologic practice and care in England, Canada, and the United States. Is there a better way? Arch Neurol (1989) 0.90
Spatial frequency discrimination in normal vision and in patients with multiple sclerosis. Brain (1982) 0.90
Relationship between neurological and urological status in patients with multiple sclerosis. J Urol (1984) 0.90
Orientation-specific losses of contrast sensitivity in multiple sclerosis. Invest Ophthalmol Vis Sci (1980) 0.88
An unusual occurrence of multiple sclerosis in a small rural community. Can J Neurol Sci (1976) 0.87
Dichotic paradigms in multiple sclerosis. Ear Hear (1984) 0.87
Carbon monoxide poisoning from Sterno. Can Med Assoc J (1978) 0.87
Tourette's syndrome: a treatable tic. Can Med Assoc J (1978) 0.85
Drug therapy in multiple sclerosis: a study of Nova Scotia senior citizens. Clin Ther (1997) 0.83
Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires. Clin Exp Immunol (2003) 0.82
Does a shift in the T-cell receptor repertoire precede the onset of MS? Neurology (1999) 0.82
Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci (1998) 0.81
Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics (2001) 0.80
Psychosocial and neurological predictors of mental health in multiple sclerosis patients. J Clin Epidemiol (1996) 0.79
Carotidynia: a cause of neck and face pain. Can Med Assoc J (1979) 0.79
Division of the recurrent laryngeal nerve for idiopathic laryngeal spasm. J Otolaryngol (1987) 0.79
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study. Mult Scler (2005) 0.78
Patients with multiple sclerosis experience hearing loss specifically for shifts of tone frequency. Arch Neurol (1984) 0.78
Haloperiodl in the treatment of stuttering. Br J Psychiatry (1977) 0.77
The effects of ABR stimulus repetition rate in multiple sclerosis. Ear Hear (1987) 0.77
Temporal arteritis. J Am Geriatr Soc (1977) 0.77
ALS incidence in Nova Scotia over a 20-year-period: a prospective study. Can J Neurol Sci (2007) 0.77
Carbon monoxide in the modern society. Can Med Assoc J (1978) 0.77
Functional competence of community-dwelling persons with multiple sclerosis using the assessment of motor and process skills. Arch Phys Med Rehabil (1994) 0.77
Amyotrophic lateral sclerosis in Nova Scotia. Adv Exp Med Biol (1987) 0.77
Narcolepsy. Can Med Assoc J (1974) 0.76
Abnormal adaptation of visual contrast sensitivity in multiple sclerosis patients. Can J Neurol Sci (1981) 0.76
Doctor Samuel Johnson's abnormal movements. Adv Neurol (1982) 0.76
Musicogenic epilepsy. Can Med Assoc J (1984) 0.76
Risks of the neurologist's pin. N Engl J Med (1979) 0.76
Degraded discrimination between speech-like sounds by patients with multiple sclerosis and Friedreich's ataxia. Brain (1984) 0.76
John Stewart's case of sudden death: a reassessment. CMAJ (1985) 0.76
The neurology of Alice in Wonderland. Can J Neurol Sci (1982) 0.76
A model clinical neuroscience curriculum. Neurology (1987) 0.76
Tourette syndrome. Can Fam Physician (1982) 0.75
Motor neuron disease in Nova Scotia. Can Med Assoc J (1974) 0.75
What should a family physician know about neurology? Can Fam Physician (1990) 0.75
Nuchal infiltrations. Can Med Assoc J (1974) 0.75
How effective are disease-modifying drugs in delaying progression in relapsing-onset ms? Neurology (2008) 0.75
Status epilepticus: a plan for management. Can Fam Physician (1983) 0.75
The management of chronic headaches. Can Fam Physician (1984) 0.75
Narcolepsy. Can Med Assoc J (1974) 0.75
THE SUCCESSFUL TREATMENT OF MENINGO-ENCEPHALITIS, ASSOCIATED WITH CANINE DISTEMPER, WITH SULFANILAMIDE. Science (1939) 0.75
No increase in multiple sclerosis among veterinarians. N Engl J Med (1981) 0.75
Neurology and the community. Can J Neurol Sci (1996) 0.75
Herniation of L4, L5 intervertebral disc--direct examination of plaintiff's biomechanical engineer. Med Trial Tech Q (1981) 0.75
Exodus of physicians. Can Med Assoc J (1984) 0.75
The Feminine Mystique. Can Med Assoc J (1964) 0.75
Delayed auditory tone perception in multiple sclerosis. Can J Neurol Sci (1983) 0.75
Letter: Multiple sclerosis and viral infections. Lancet (1976) 0.75
Multiple sclerosis in a rural community. Neurology (1976) 0.75
L-dopa therapy in Parkinson's disease. N S Med Bull (1972) 0.75
Hearing changes in multiple sclerosis. J Neurosurg Nurs (1983) 0.75
Childhood M.S. Can Nurse (1982) 0.75
Conceptual reasoning as a mediator of verbal recall in patients with multiple sclerosis. J Clin Exp Neuropsychol (1996) 0.75